Market Insights Health Hospitals Inpatient Care

Treatment of Cardiovascular Diseases - Ivory Coast

Ivory Coast

In Ivory Coast, the Treatment of Cardiovascular Diseases market is projected to generate a revenue of US$195.50m in 2024.
Looking ahead, this market segment is expected to experience a steady annual growth rate (CAGR 2024-2029) of 6.27%, resulting in a market volume of US$265.00m by 2029.
However, when comparing globally, it is important to note that in the United States is expected to generate the highest revenue in this market segment, reaching a staggering US$136.00bn in 2024.
In Ivory Coast, the treatment of cardiovascular diseases is becoming more accessible through the expansion of healthcare infrastructure and increased awareness campaigns.

Key regions: China, India, United States, France, Canada

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.